41
/
AIzaSyB4mHJ5NPEv-XzF7P6NDYXjlkCWaeKw5bc
May 31, 2026
3512550
319423
2
Public Timelines
FAQ

jan 1, 1997 - Rituximab

Description:

For use in patients with treatment-resistant, low-grade or follicular B-cell non-Hodgkin lymphoma (NHL), the Food and Drug Administration (FDA) approves rituximab, a monoclonal antibody.

Added to timeline:

14 Nov 2019
0
0
309

Date:

jan 1, 1997
Now
~ 29 years ago